The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
In silico clinical trials: concepts and early adoptions
Abstract
Innovations in information and communication technology infuse all branches of science, including life sciences. Nevertheless, healthcare is historically slow in adopting technological innovation, compared with other industrial sectors. In recent years, new approaches in modelling and simulation have started to provide important insights in biomedicine, opening the way for their potential use in the reduction, refinement and partial substitution of both animal and human experimentation. In light of this evidence, the European Parliament and the United States Congress made similar recommendations to their respective regulators to allow wider use of modelling and simulation within the regulatory process. In the context of in silico medicine, the term ‘in silico clinical trials’ refers to the development of patient-specific models to form virtual cohorts for testing the safety and/or efficacy of new drugs and of new medical devices. Moreover, it could be envisaged that a virtual set of patients could complement a clinical trial (reducing the number of enrolled patients and improving statistical significance), and/or advise clinical decisions. This article will review the current state of in silico clinical trials and outline directions for a full-scale adoption of patient-specific modelling and simulation in the regulatory evaluation of biomedical products. In particular, we will focus on the development of vaccine therapies, which represents, in our opinion, an ideal target for this innovative approach.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Systems biology: a brief overview
Kitano, H. (2002) · Science · doi:10.1126/science.1069492 · Cited by 4,265
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
Shankaran, V., Ikeda, H., Bruce, A. T., White, J. M., Swanson, P. E., Old, L. J., & Schreiber, R. D. (2001) · Nature · doi:10.1038/35074122 · Cited by 2,896
A N EW A PPROACH TO D ECODING L IFE : Systems Biology
Ideker, T., Galitski, T., & Hood, L. (2001) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.2.1.343 · Cited by 1,664
Some suggestions for measuring predictive performance
Sheiner, L. B., & Beal, S. L. (1981) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01060893 · Cited by 1,617
Role of Molecular Dynamics and Related Methods in Drug Discovery
De Vivo, M., Masetti, M., Bottegoni, G., & Cavalli, A. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01684 · Cited by 1,297
Lindbom, L., Pihlgren, P., & Jonsson, N. (2005) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2005.04.005 · Cited by 1,135
Peters, B., & Sette, A. (2005) · BMC Bioinformatics · doi:10.1186/1471-2105-6-132 · Cited by 512
Reverse vaccinology, a genome-based approach to vaccine development
Rappuoli, R. (2001) · Vaccine · doi:10.1016/s0264-410x(00)00554-5 · Cited by 497
Computational fluid dynamics modelling in cardiovascular medicine
Morris, P. D., Narracott, A., von Tengg-Kobligk, H., Silva Soto, D. A., Hsiao, S., Lungu, A., Evans, P., Bressloff, N. W., Lawford, P. V., Hose, D. R., et al. (2016) · Heart · doi:10.1136/heartjnl-2015-308044 · Cited by 495
De Vito, C., Angeloni, C., De Feo, E., Marzuillo, C., Lattanzi, A., Ricciardi, W., Villari, P., & Boccia, S. (2014) · BioMed Research International · doi:10.1155/2014/304602 · Cited by 451
Phenotypic vs. Target-Based Drug Discovery for First-in-Class Medicines
Swinney, D. C. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.236 · Cited by 413
PBPK modeling and simulation in drug research and development
Zhuang, X., & Lu, C. (2016) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2016.04.004 · Cited by 410
Passini, E., Britton, O. J., Lu, H. R., Rohrbacher, J., Hermans, A. N., Gallacher, D. J., Greig, R. J. H., Bueno-Orovio, A., & Rodriguez, B. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00668 · Cited by 326
In silico clinical trials: how computer simulation will transform the biomedical industry
Viceconti, M., Henney, A., & Morley-Fletcher, E. (2016) · International Journal of Clinical Trials · doi:10.18203/2349-3259.ijct20161408 · Cited by 289
Self-citationIn silico ADME-Tox modeling: progress and prospects
Alqahtani, S. (2017) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2017.1389897 · Cited by 231
Taylor, M., & Prendergast, P. J. (2015) · Journal of Biomechanics · doi:10.1016/j.jbiomech.2014.12.019 · Cited by 199
Application of Petri net based analysis techniques to signal transduction pathways
Sackmann, A., Heiner, M., & Koch, I. (2006) · BMC Bioinformatics · doi:10.1186/1471-2105-7-482 · Cited by 189
A Genomic-Systems Biology Map for Cardiovascular Function
Stoll, M., Cowley, A. W., Tonellato, P. J., Greene, A. S., Kaldunski, M. L., Roman, R. J., Dumas, P., Schork, N. J., Wang, Z., & Jacob, H. J. (2001) · Science · doi:10.1126/science.1062117 · Cited by 168
Prediction of MHC-Peptide Binding: A Systematic and Comprehensive Overview
Lafuente, E., & Reche, P. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209789105162 · Cited by 160
An FDA Viewpoint on Unique Considerations for Medical-Device Clinical Trials
Faris, O., & Shuren, J. E. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1512592 · Cited by 152
Topological Analysis of Metabolic Networks Based on Petri Net Theory
Zevedei-Oancea, I., & Schuster, S. (2011) · Studies in health technology and informatics · doi:10.3233/978-1-60750-704-8-17 · Cited by 118
Qasim, M., Farinella, G., Ju, Z., Li, X., Yang, L., Eastell, R., & Viceconti, M. (2016) · Osteoporosis International · doi:10.1007/s00198-016-3597-4 · Cited by 110
Self-citationIn silico repurposing of antipsychotic drugs for Alzheimer’s disease
Kumar, S., Chowdhury, S., & Kumar, S. (2017) · BMC Neuroscience · doi:10.1186/s12868-017-0394-8 · Cited by 103
Carusi, A., Burrage, K., & Rodríguez, B. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01151.2011 · Cited by 102
The Virtual Physiological Human: Ten Years After
Viceconti, M., & Hunter, P. J. (2016) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-110915-114742 · Cited by 102
Self-citationT-Cell Epitope Prediction Methods: An Overview
Desai, D. V., & Kulkarni‐Kale, U. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-1115-8_19 · Cited by 101
Advancing drug discovery through systems biology
Davidov, E., Holland, J., Marple, E. W., & Naylor, S. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02600-x · Cited by 98
A physiologically based pharmacokinetic computer model for human pregnancy
Luecke, R. H., Wosilait, W. D., Pearce, B. A., & Young, J. F. (1994) · Teratology · doi:10.1002/tera.1420490205 · Cited by 91
Caiazzo, A., Evans, D., Falcone, J.-L., Hegewald, J., Lorenz, E., Stahl, B., Wang, D., Bernsdorf, J., Bastien Chopard, B., Gunn, J. P., et al. (2011) · Journal of Computational Science · doi:10.1016/j.jocs.2010.09.002 · Cited by 91
Modeling Biology Spanning Different Scales: An Open Challenge
Castiglione, F., Pappalardo, F., Bianca, C., Russo, G. L., & Motta, S. (2014) · BioMed Research International · doi:10.1155/2014/902545 · Cited by 88
Self-citationThe Virtual Physiological Human — A European Initiative for in silico Human Modelling —
Viceconti, M., Clapworthy, G., & Jan, S. V. S. (2008) · The Journal of Physiological Sciences · doi:10.2170/physiolsci.rp009908 · Cited by 86
Self-citationTrauma in silico: Individual-specific mathematical models and virtual clinical populations
Brown, D., Namas, R. A., Almahmoud, K., Zaaqoq, A. M., Sarkar, J., Barclay, D. A., Yin, J., Ghuma, A., Abboud, A., Constantine, G. M., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa3636 · Cited by 80
Simulating Properties of In Vitro Epithelial Cell Morphogenesis
Grant, M. R., Mostov, K. E., Tlsty, T. D., & Hunt, C. A. (2005) · PLoS Computational Biology · doi:10.1371/journal.pcbi.0020129 · Cited by 76
Viceconti, M., Cobelli, C., Haddad, T. D., Himes, A. K., Kovatchev, B. P., & Palmer, M. (2017) · Proceedings of the Institution of Mechanical Engineers Part H Journal of Engineering in Medicine · doi:10.1177/0954411917702931 · Cited by 66
Self-citationHaddad, T., Himes, A., Thompson, L., Irony, T., Nair, R., & on Behalf of MDIC Computer Modeling and Simulation Working Group Participants (2017) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543406.2017.1300907 · Cited by 62
Rejniak, K. A., & McCawley, L. J. (2010) · Experimental Biology and Medicine · doi:10.1258/ebm.2009.009230 · Cited by 62
An, G. C., Bartels, J. D., & Yoram Vodovotz, B. (2010) · Drug Development Research · doi:10.1002/ddr.20415 · Cited by 60
Definition of MHC Supertypes Through Clustering of MHC Peptide-Binding Repertoires
Reche, P. A., & Reinherz, E. L. (2007) · Methods in molecular biology · doi:10.1007/978-1-60327-118-9_11 · Cited by 59
Kim, P., & Lee, P. P. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002742 · Cited by 58
Finn, O. J., & Beatty, P. L. (2016) · Current Opinion in Immunology · doi:10.1016/j.coi.2016.01.002 · Cited by 58
Major histocompatibility complex linked databases and prediction tools for designing vaccines
Singh, S. P., & Mishra, B. N. (2015) · Human Immunology · doi:10.1016/j.humimm.2015.11.012 · Cited by 54
In silico clinical trials for pediatric orphan diseases
Carlier, A., Vasilevich, A. S., Maréchal, M., de Boer, J., & Geris, L. (2018) · Scientific Reports · doi:10.1038/s41598-018-20737-y · Cited by 53
Vaccine protocols optimization: In silico experiences
Pappalardo, F., Pennisi, M. A., Castiglione, F., & Motta, S. (2009) · Biotechnology Advances · doi:10.1016/j.biotechadv.2009.10.001 · Cited by 48
Self-citationGenerating Virtual Patients by Multivariate and Discrete Re-Sampling Techniques
Teutonico, D., Musuamba, F. T., Maas, H. J., Facius, A., Yang, S., Danhof, M., & Pasqua, O. E. D. (2015) · Pharmaceutical Research · doi:10.1007/s11095-015-1699-x · Cited by 47
Phenotypic transition maps of 3D breast acini obtained by imaging-guided agent-based modeling
Tang, J., Enderling, H., Becker-Weimann, S., Pham, C. J., Polyzos, A. A., Chen, C.-Y., & Costes, S. V. (2011) · Integrative Biology · doi:10.1039/c0ib00092b · Cited by 47
A computational model to predict the immune system activation by citrus-derived vaccine adjuvants
Pappalardo, F., Fichera, E., Paparone, N., Lombardo, A., Pennisi, M. A., Russo, G. L., Leotta, M., Pappalardo, F., Pedretti, A., Fiore, F. D., et al. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btw293 · Cited by 47
Self-citationYonucu, S., Yιlmaz, D., Phipps, C., Unlu, M. B., & Kohandel, M. (2017) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005724 · Cited by 46
Lü, Y., Boudiffa, M., Dall’Ara, E., Liu, Y., Bellantuono, I., & Viceconti, M. (2017) · Journal of the mechanical behavior of biomedical materials/Journal of mechanical behavior of biomedical materials · doi:10.1016/j.jmbbm.2017.07.034 · Cited by 38
Self-citationFracture prediction of cardiac lead medical devices using Bayesian networks
Haddad, T. D., Himes, A. K., & Campbell, M. (2013) · Reliability Engineering & System Safety · doi:10.1016/j.ress.2013.11.005 · Cited by 37
Gullo, F., van der Garde, M., Russo, G. L., Pennisi, M. A., Motta, S., Pappalardo, F., & Watt, S. M. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btv172 · Cited by 36
Self-citationPredicting mouse vertebra strength with micro-computed tomography-derived finite element analysis
Nyman, J. S., Uppuganti, S., Makowski, A. J., Rowland, B. J., Merkel, A. R., Sterling, J. A. R., Bredbenner, T. L., & Perrien, D. S. (2015) · BoneKEy Reports · doi:10.1038/bonekey.2015.31 · Cited by 32
High-dimensional therapeutic inference in the focally damaged human brain
Xu, T., Jäger, H. R., Husain, M., Rees, G. E., & Nachev, P. (2017) · Brain · doi:10.1093/brain/awx288 · Cited by 32
In silico modeling to optimize interpretation of liver safety biomarkers in clinical trials
Church, R. J., & Watkins, P. B. (2017) · Experimental Biology and Medicine · doi:10.1177/1535370217740853 · Cited by 29
The analysis of glucose measurements by computer simulation.
Janes, R. G., & Osburn, J. O. (1965) · The Journal of Physiology · doi:10.1113/jphysiol.1965.sp007745 · Cited by 20
Application of Physiologically Based Pharmacokinetic Models for Assessing Drug Disposition in Space
Srinivasan, R. S., Bourne, D. W. A., & Putcha, L. (1994) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1994.tb02025.x · Cited by 17
Continuous Petri Nets and microRNA Analysis in Melanoma
Russo, G. L., Pennisi, M. A., Boscarino, R., & Pappalardo, F. (2017) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2017.2733529 · Cited by 14
Self-citationAndreoni, C., Orsi, G., Maria, C. D., Montemurro, F., & Vozzi, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111946 · Cited by 11
The IUPS Physiome Project. International Union of Physiological Sciences.
Hunter, P. J., Nielsen, P. M. F., & Bullivant, D. P. (2002) · PubMed · Cited by 9
Yenkie, K. M., & Diwekar, U. M. (2014) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2014.04.013 · Cited by 8
Research works printed but not linked: 15
- Silverman, 1961, Application of analogue computer to measurement of intestinal absorption rates with tracers, J Appl Physiol, 16, 911, 10.1152/jappl.1961.16.5.911 · doi:10.1152/jappl.1961.16.5.911
- Nichol, 1977, Pharmacokinetics: selectivity of action related to physicochemical properties and kinetic patterns of anticancer drugs, Cancer, 40, 519, 10.1002/1097-0142(197707)40:1+<519::AID-CNCR2820400718>3.0.CO;2-4 · doi:10.1002/1097-0142(197707)40:1+<519::aid-cncr2820400718>3.0.co;2-4
- Cogan, 1984, Regulation of proximal bicarbonate reabsorption, Am J Physiol, 247, F387
- Byczkowski, 1994, Computer simulation of the lactational transfer of tetrachloroethylene in rats using a physiologically based model, Toxicol Appl Pharmacol, 125, 228, 10.1006/taap.1994.1068 · doi:10.1006/taap.1994.1068
- Bassingthwaighte, 1997, Design and strategy for the Cardionome Project, Adv Exp Med Biol, 430, 325, 10.1007/978-1-4615-5959-7_28 · doi:10.1007/978-1-4615-5959-7_28
- Popel, 1998, The microcirculation physiome project, Ann Biomed Eng, 26, 911, 10.1114/1.112 · doi:10.1114/1.112
- Calonaci, 2012, Optimal vaccination schedule search using genetic algorithm over MPI technology, BMC Med Inform Decis Mak, 12, 129., 10.1186/1472-6947-12-129 · doi:10.1186/1472-6947-12-129
- Peleg, 2004, Using Petri Net tools to study properties and dynamics of biological systems, J Am Med Inform Assoc, 12, 181, 10.1197/jamia.M1637 · doi:10.1197/jamia.m1637
- Cordero, 2013, Multi-level model for the investigation of oncoantigen-driven vaccination effect, BMC Bioinformatics, 14, S11., 10.1186/1471-2105-14-S6-S11 · doi:10.1186/1471-2105-14-s6-s11
- Pennisi, 2016, A methodological approach for using high-level Petri Nets to model the immune system response, BMC Bioinformatics, 17, 498, 10.1186/s12859-016-1361-6 · doi:10.1186/s12859-016-1361-6
- Lemon, 2016, The use of mathematical modelling for improving the tissue engineering of organs and stem cell therapy, Curr Stem Cell Res Ther, 11, 666, 10.2174/1574888X10666151001115942 · doi:10.2174/1574888x10666151001115942
- Ravvaz, 2017, Personalized anticoagulation: optimizing Warfarin management using genetics and simulated clinical trials, Circ Cardiovasc Genet, 10, e001804, 10.1161/CIRCGENETICS.117.001804 · doi:10.1161/circgenetics.117.001804
- Pappalardo, 2015, Computational modelling approaches to vaccinology, Pharmacol Res, 92, 40, 10.1016/j.phrs.2014.08.006 · doi:10.1016/j.phrs.2014.08.006
- Viceconti, 2009, Pre-clinical validation of joint prostheses: a systematic approach, J Mech Behav Biomed Mater, 2, 120, 10.1016/j.jmbbm.2008.02.005 · doi:10.1016/j.jmbbm.2008.02.005
- Alemani, 2012, Combining cellular automata and Lattice Boltzmann method to model multiscale avascular tumor growth coupled with nutrient diffusion and immune competition, J Immunol Methods, 376, 55, 10.1016/j.jim.2011.11.009 · DOI
Cited by
The ‘Digital Twin’ to enable the vision of precision cardiology
Corral-Acero, J., Margara, F., Marciniak, M., Rodero, C., Loncaric, F., Feng, Y., Gilbert, A., Fernandes, J. F., Bukhari, H. A., Wajdan, A., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa159 · Cited by 932
Lekadir, K., Frangi, A. F., Porras, A. R., Glocker, B., Cintas, C., Langlotz, C. P., Weicken, E., Asselbergs, F. W., Prior, F., Collins, G. S., et al. (2025) · BMJ · doi:10.1136/bmj-2024-081554 · Cited by 957
Viceconti, M., Pappalardo, F., Rodriguez, B., Horner, M., Bischoff, J., & Musuamba Tshinanu, F. (2021) · Methods · doi:10.1016/j.ymeth.2020.01.011 · Cited by 361
“Thus, human in silico clinical trials are now emerging as an important paradigm in the development of medical therapies [6].”
BackgroundSelf-citationFDA Perspective on the Regulation of Artificial Intelligence in Health Care and Biomedicine
Warraich, H. J., Tazbaz, T., & Califf, R. M. (2025) · JAMA · doi:10.1001/jama.2024.21451 · Cited by 332
Synthetic data in health care: A narrative review
Gonzales, A., Guruswamy, G., & Smith, S. R. (2023) · PLOS Digital Health · doi:10.1371/journal.pdig.0000082 · Cited by 308
Metadata
- Authors
- Pappalardo, F., Russo, G., Tshinanu, F. M., & Viceconti, M.
- Venue
- Briefings in Bioinformatics
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-06-02
- Volume
- 20
- Issue
- 5
- Pages
- 1699-1708
- ISSN
- 1467-5463 (ISSN-L)
- 1477-4054
- OpenAlex
- W2806810105
- Cited by
- 279
- References
- 59
- FWCI
- 10.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.